R&D Evaluating methods targeting Protein-Protein Interactions Protein-protein interactions (PPIs) are becoming increasingly relevant in the pathology of many diseases, including cancer.
News NICE relents on Takeda colorectal cancer drug Fruzaqla Colorectal cancer patients could soon have access via the NHS to a targeted oral drug that can give them more precious time with their loved ones.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face